echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > Neurology: Impaired white matter integrity in adolescents infected with HIV during the perinatal period

    Neurology: Impaired white matter integrity in adolescents infected with HIV during the perinatal period

    • Last Update: 2022-10-19
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Despite the efficacy of combination antiretroviral therapy (cART), adolescent patients with perinatally acquired HIV (PHIV) still exhibit cognitive dysfunction, the structural changes of which may be underlying pathophysiology.

    Previous
    MRI studies have found smaller brain volume, higher white matter (WM) high intensity (WMH) volume, lower white matter integrity, and greater
    differences in cerebral blood flow (CBF).
    However, these findings may be confused with adoption status, as a large percentage
    of adolescents carrying PHIV are adopted
    .
    Adoption is associated with malnutrition and neglect, which in turn may affect brain development
    .

    van Genderen, Department of Pediatric Infectious Diseases, UMC Emma Children's Hospital, Amsterdam, the Netherlands, published a research article in Neuorology investigating the long-term effects of PHIV on the brain.
    At the same time, the confounding effect of adoption status is minimized
    .

    The study included cART-treated adolescent PHIV patients and controls
    matched for age, sex, ethnicity, socioeconomic status, and adoption status.
    The study determined
    whole brain gray matter (GM) and WM volume by 3D T1-weighted scanning; Determine the total WMH volume with T2FLAIR; CBFs in the following regions of interest (ROIs) were analyzed with arterial spin labeling sequences: WM, GM, and subcortical GM ; Whole brain WM microstructural markers were analyzed using diffusion tensor imaging sequences: partial anisotropy (FA), mean diffusivity (MD), axial diffusivity (AD ), and radial diffusivity (RD)
    。 Differences in neuroimaging parameters between adolescents and controls with PHIV were assessed using an age- and sex-adjusted linear regression model and applying multiple comparative corrections
    .

     The study included 35 adolescent PHIV patients and 38 controls with a median age of 14.
    9
    (IQR) : 10.
    7-18.
    5
    ) and 15.
    6 (IQR: 11.
    1-17.
    6
    ) years, with similar adoption status

    1.
    The study found that juvenile PHIV patients had lower overall FA compared with control (beta = –0.
    012
    ; p < 0.
    014, –2.
    4%), MD (beta = 0.
    014, p = 0.
    014, 1.
    3%)
    , and RD (beta = 0.
    02, p = 0.
    014, 3.
    3%)
    , but no difference
    in AD.

    Figure 1.
    Scatterplot showing WM integrity parameters for PHIV (blue) and HIV-negative matched control (red) adolescents

    2.
    The study found GM, WM, and WMH in ROI in adolescent PHIV patients and controls The volume is comparable
    to CBF.

    Table 2.
    Brain volume, white matter integrity, and cerebral blood flow in adolescent PHIV patients versus controls

    3.
    No association
    was found between cognitive characteristics and WM microstructural markers in adolescents with PHIV.

    Table 3.
    Correlation analysis of WM microstructure and PHIV characteristics

    Despite the effectiveness of treatment, adolescents with PHIV had lower
    WM integrity compared with controls, regardless of international adoption status.
    These results highlight the neuropathogenic nature of HIV or, to a lesser extent, its treatment
    .
    Although
    there was no difference between groups in GM, WM, and WMH volumes and CBF in ROIs, it was because Adolescents with PHIV are often affected by cognitive impairment and experience lifelong illness and treatment, and these findings warrant follow-up
    .

    Original source

    Brain Differences in Adolescents Living With Perinatally Acquired HIV Compared With Adoption Status Matched Controls A Cross-sectional Study.
    Neurology Oct 2022, 99 (15) e1676-e1684; DOI: 10.
    1212/WNL.
    0000000000200946

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.